Stockscreener 앱 받기
17.43
1.63%
0.28
시간 외 거래:
17.35
-0.08
-0.46%
전일 마감가:
$17.15
열려 있는:
$17.06
하루 거래량:
1.82M
Relative Volume:
0.92
시가총액:
$1.21B
수익:
$1.03B
순이익/손실:
$-94.55M
주가수익비율:
-12.44
EPS:
-1.4012
순현금흐름:
$-3.64M
1주 성능:
+7.33%
1개월 성능:
+6.41%
6개월 성능:
-15.72%
1년 성능:
+18.89%
1일 변동 폭
$16.89
$17.56
1주일 범위
$16.00
$17.56
52주 변동 폭
$12.26
$29.65
Tandem Diabetes Care Inc Stock (TNDM) Company Profile
명칭
Tandem Diabetes Care Inc
전화
858-366-6900
주소
12400 HIGH BLUFF DRIVE, San Diego, CA
Compare TNDM vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TNDM
Tandem Diabetes Care Inc
|
17.43 | 1.21B | 1.03B | -94.55M | -3.64M | -1.4012 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.15 | 117.81B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.69 | 66.22B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.07 | 51.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
Tandem Diabetes Care Inc Stock (TNDM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-10-07 | 개시 | Barclays | Equal Weight |
| 2026-09-30 | 재확인 | Citigroup | Neutral |
| 2026-08-21 | 개시 | William Blair | Outperform |
| 2026-07-28 | 재개 | UBS | Neutral |
| 2026-06-23 | 개시 | Deutsche Bank | Hold |
| 2026-06-01 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2026-05-12 | 개시 | The Benchmark Company | Hold |
| 2026-03-19 | 업그레이드 | Truist | Hold → Buy |
| 2026-03-17 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2026-02-23 | 업그레이드 | Lake Street | Hold → Buy |
| 2026-02-20 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2026-01-27 | 재개 | TD Cowen | Buy |
| 2025-12-16 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2025-10-21 | 재개 | Stifel | Hold |
| 2025-09-08 | 개시 | Oppenheimer | Outperform |
| 2025-08-12 | 업그레이드 | Citigroup | Sell → Neutral |
| 2025-08-07 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2025-07-09 | 다운그레이드 | Citigroup | Neutral → Sell |
| 2025-06-16 | 개시 | Truist | Hold |
| 2025-04-10 | 개시 | Mizuho | Neutral |
| 2025-03-05 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2025-03-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2025-03-03 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2025-02-28 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2024-12-02 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-06 | 개시 | Bernstein | Outperform |
| 2024-10-04 | 개시 | Goldman | Neutral |
| 2024-10-02 | 개시 | RBC Capital Mkts | Outperform |
| 2024-08-22 | 개시 | Morgan Stanley | Equal-Weight |
| 2024-08-08 | 개시 | Canaccord Genuity | Buy |
| 2024-05-30 | 개시 | Redburn Atlantic | Buy |
| 2024-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2024-04-29 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2024-04-25 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2024-03-26 | 업그레이드 | Stifel | Hold → Buy |
| 2023-08-04 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2023-05-05 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-04-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2023-03-29 | 개시 | UBS | Neutral |
| 2023-01-26 | 개시 | Wolfe Research | Peer Perform |
| 2022-11-15 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-08-09 | 다운그레이드 | Wells Fargo | Overweight → Underweight |
| 2022-03-02 | 재개 | BofA Securities | Neutral |
| 2022-01-19 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2021-07-21 | 재개 | Cowen | Outperform |
| 2021-05-25 | 개시 | Barclays | Underweight |
| 2020-12-15 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2020-08-20 | 개시 | Wells Fargo | Overweight |
| 2020-07-31 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2020-07-06 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-06-18 | 재확인 | Raymond James | Outperform |
| 2020-04-24 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-03-23 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2020-03-05 | 개시 | Citigroup | Neutral |
| 2020-02-06 | 개시 | Raymond James | Outperform |
| 2020-02-04 | 다운그레이드 | Robert W. Baird | Outperform → Neutral |
| 2019-10-18 | 개시 | Guggenheim | Buy |
| 2019-10-04 | 업그레이드 | UBS | Neutral → Buy |
| 2019-05-17 | 재확인 | BofA/Merrill | Neutral |
| 2019-05-13 | 개시 | SVB Leerink | Outperform |
| 2019-03-08 | 개시 | BMO Capital Markets | Outperform |
| 2019-03-05 | 재확인 | BofA/Merrill | Neutral |
| 2019-02-27 | 재확인 | Lake Street | Buy |
| 2018-11-21 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2018-09-26 | 재확인 | Dougherty & Company | Buy |
| 2018-09-26 | 재확인 | Piper Jaffray | Overweight |
모두보기
Tandem Diabetes Care Inc 주식(TNDM)의 최신 뉴스
Form 4 Tandem Diabetes Care Inc: Jean-Claude Kyrillos (EVP & Chief Operating Officer) For: 15 October - Investing.com Nigeria
After a COO stock conversion, Tandem Diabetes Care (TNDM) withheld 1,926 shares for taxes; none were sold. - Stock Titan
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo! Finance Canada
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance UK
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
Tandem Diabetes Care Q2 2026 Earnings Call Transcript - Benzinga
App Recall Might Change The Case For Investing In Tandem Diabetes Care (TNDM) - Simply Wall Street
Tandem Diabetes Care, Inc. (TNDM) Stock forecasts - Yahoo Finance Singapore
Is it the Right Time to Hold TNDM Stock in Your Portfolio? - Zacks Investment Research
Is it the Right Time to Hold TNDM Stock in Your Portfolio? - TradingView
Barclays Downgrades Tandem Diabetes Care(TNDM.US) to Hold Rating, Cuts Target Price to $18 - Moomoo
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
Barclays Keeps Their Hold Rating on Tandem Diabetes Care (TNDM) - The Globe and Mail
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
Tandem Diabetes Care, Inc. (0M0F.L) stock price, news, quote and history - Yahoo Finance Australia
RBC Capital Maintains Tandem Diabetes Care(TNDM.US) With Buy Rating, Maintains Target Price $26 - Moomoo
Tandem Diabetes Care to Announce Third Quarter 2026 Financial Results on November 5, 2026 - Business Wire
Tandem Diabetes Care (NasdaqGM:TNDM) Stock Forecast & Analyst Predictions - Simply Wall Street
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
Tandem Diabetes Care (TNDM) Is Up 7.2% After International Launch Of Mobi Insulin Pump System - Yahoo Finance
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks - Yahoo Finance
Operating cash flow per share of Tandem Diabetes Care, Inc. – HAN:TD5A - tradingview.com
Tandem Diabetes Care, Inc. (0M0F.L) Stock Price, News, Quote & History - Yahoo! Finance Canada
Tandem Diabetes (TNDM) Expands Mobi Insulin Delivery System to 1 - GuruFocus
Tandem Diabetes Expands Insulin Delivery System to 12 New Countries - Moomoo
Tandem Diabetes Expands Insulin Delivery System to 12 New Countries - Yahoo Finance
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets - News-Press NOW
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets - Yahoo Finance
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets - Business Wire
Tandem Mobi Automated Insulin Delivery System Now Available in Twelve International Markets - Nasdaq
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo! Finance Canada
A Look at Tandem Diabetes Care Inc (TNDM) After 3.3% Gain -- GF Value $24.10 vs Price $15.72 - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
Truist Lowers Price Target on Tandem Diabetes Care to $28 From $31, Keeps Buy Rating - marketscreener.com
Truist Lowers Price Target on Tandem Diabetes Care to $28 From $31, Keeps Buy Rating - Yahoo Finance
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - finance.yahoo.com
Surgery Partners, 10x Genomics, QuidelOrtho, Zimmer Biomet, and Tandem Diabetes Stocks Trade Down, What You Need To Know - Yahoo Finance
A Look at Tandem Diabetes Care Inc (TNDM) After 6.4% Decline -- GF Value $24.09 vs Price $16.38 - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) Stock Analysis: Exploring a 62.88% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Tandem Diabetes Care, Inc. (TNDM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Is Tandem Diabetes Care (TNDM) Undervalued As Investors Weigh Its 34% One Year Return? - Yahoo Finance
Officer at Tandem Diabetes Care (NASDAQ: TNDM) plans 360-share stock sale - Stock Titan
Tandem Diabetes Care (TNDM) Soars 7.7%: Is Further Upside Left in the Stock? - Yahoo Finance
A Look at Tandem Diabetes Care Inc (TNDM) After 7.7% Gain -- GF Value $24.08 vs Price $17.54 - GuruFocus
Tandem Diabetes Care, Inc. (TNDM) Stock Forecasts - Yahoo Finance
(TNDM) Volatility Zones as Tactical Triggers - Stock Traders Daily
Tandem Diabetes Care: Stop Paying For Tomorrow's ProfitsStrong Sell (NASDAQ:TNDM) - Seeking Alpha
Is Tandem Diabetes Care Inc (TNDM) a Bargain After 4.2% Drop? GF Value Says Undervalued - GuruFocus
Is Tandem Diabetes Care Inc (TNDM) a Bargain After 4.2% Drop? GF Value Says Undervalued - GuruFocus
Zacks Investment Research - גלובס
Tandem Diabetes Care Inc (TNDM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Tandem Diabetes Care Inc 주식 (TNDM) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| MARK NOVARA | Officer |
Sep 17 '26 |
Proposed Sale |
17.53 |
360 |
6,311 |
0 |
| MARK NOVARA | Officer |
Aug 18 '26 |
Proposed Sale |
22.26 |
131 |
2,915 |
0 |
| Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
3,014 |
0 |
2,425 |
| Carpenter Rick | EVP & Chief Technology Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
2,507 |
0 |
32,968 |
| Hansen Shannon Marie | EVP & Chief Legal Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
3,014 |
0 |
32,626 |
| Sheridan John F | PRESIDENT & CEO |
Aug 15 '26 |
Option Exercise |
0.00 |
15,916 |
0 |
165,315 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
1,010 |
0 |
30,825 |
| Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Aug 15 '26 |
Option Exercise |
0.00 |
4,120 |
0 |
52,982 |
| Morrison Susan | EVP & Chief Admin. Officer |
Aug 15 '26 |
Option Exercise |
0.00 |
2,827 |
0 |
53,283 |
| Kyrillos Jean-Claude | EVP & Chief Operating Officer |
Jul 15 '26 |
Option Exercise |
0.00 |
3,636 |
0 |
31,741 |
2.36%
7.07%
자본화:
|
볼륨(24시간):